Bethanechol

DRUG5 trials

Sponsors

Augusta University, University of Iowa, Columbia University, Susan E. Bates, Arkansas Children's Hospital Research Institute

Conditions

Eosinophilic Esophagitis (EoE)Esophageal DysmotilityPancreas CancerTracheobronchomalacia

Early Phase 1

Bethanechol Prior to Pancreatic Surgery

CompletedNCT03572283

Columbia UniversityPancreas Cancer

Start: 2018-04-08End: 2023-08-24Updated: 2025-06-05

Phase 1

Topical Bethanechol for Improvement of Esophageal Dysmotility

CompletedNCT01031043

Augusta UniversityEsophageal Dysmotility

Start: 2009-11-30End: 2012-04-30Updated: 2015-01-29

Phase 2

Bethanechol for Eosinophilic Esophagitis

TerminatedNCT02058537

University of IowaEosinophilic Esophagitis (EoE)

Start: 2014-02-28End: 2014-07-31Updated: 2016-04-22

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

RecruitingNCT05241249

Susan E. BatesPancreas Cancer

Start: 2022-02-01End: 2026-01-31Target: 37Updated: 2025-06-05

Unknown Phase

The Effect of Bethanechol on Tracheobronchomalacia

RecruitingNCT05299008

Arkansas Children's Hospital Research InstituteTracheobronchomalacia

Start: 2022-08-11End: 2024-06-30Target: 20Updated: 2024-01-30

Related Papers

A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgery

The Oncologist2025-05-311 citations